Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ADBE stock price vs CI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CI's multiple
Needs CI P/E.
Implied fair value · at ADBE's multiple
Needs ADBE P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ADOBE INC. · implied price per share
Bear
$260.76
Base
$306.53
Bull
$366.14
The Cigna Group · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
ADBE vs MSFT
Salesforce, Inc.
ADBE vs CRM
ORACLE CORP
ADBE vs ORCL
INTERNATIONAL BUSINESS MACHINES CORP
ADBE vs IBM
TYLER TECHNOLOGIES INC
ADBE vs TYL
Autodesk, Inc.
ADBE vs ADSK
UNITEDHEALTH GROUP INC
ADBE vs UNH
CVS HEALTH Corp
ADBE vs CVS
HUMANA INC
ADBE vs HUM
CENTENE CORP
ADBE vs CNC
WEST PHARMACEUTICAL SERVICES INC
ADBE vs WST
BAXTER INTERNATIONAL INC
ADBE vs BAX
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ADBE can maintain its premium margins and ROIC without a valuation reset, then hold or add selectively only on weakness because the current price still screens above both the DCF range and the P/E-derived implied value.
ADBE trades above the implied P/E-derived value of $212.70, suggesting about 19.8% downside from the current price of $265.21. The stock is also above the top end of the DCF range and slightly above the top of the historical band, indicating valuation is not cheap even with strong fundamentals.
Supporting Metrics
